Cite
HARVARD Citation
Tang, H. et al. (2022). Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study. Therapeutic advances in musculoskeletal disease. p. . [Online].